Taxonomical and biological notes on Argentoleon irrigatus (Gerstaecker) (Neuroptera: Myrmeleontidae).

Argentoleon irrigatus (Gerstaecker), is a common antlion species, but with sparse figures and incomplete location records in the literature, whose genitalia and larvae remained undescribed. Herein, the adults are redescribed and immatures (larvae and pupa) are described for the first time, providing images of internal and external characters, including both male and female genitalia. The examination and illustration of these characters allowed us to better understand the position and the limits of the genus Argentoleon Stange, within the tribe Brachynemurini, including the differentiation of the larval stages of the closely related genus Austroleon Banks.

Clinical and transcriptomic characteristics of a novel SMARCD2 mutation that disrupts neutrophil maturation and function.

We report a novel case of SMARCD2 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 2) mutation successfully treated with hematopoietic stem cell transplantation. The female patient presented delayed cord separation, chronic diarrhea, skin abscesses, skeletal dysmorphisms, and neutropenia with specific granule deficiency. Analysis of the transcriptomic profile of peripheral blood sorted mature and immature SMARCD2 neutrophils showed defective maturation process that associated with altered expression of genes related to specific, azurophilic, and gelatinase granules, such as LTF, CRISP3, PTX3, and CHI3L1.

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy.

The care of systemic amyloidosis has improved dramatically due to improved awareness, accurate diagnostic tools, the development of powerful prognostic and companion biomarkers, and a continuous flow of innovative drugs, which translated into the blooming of phase 2/3 interventional studies for light chain (AL) and transthyretin (ATTR) amyloidosis. The unprecedented availability of effective drugs ignited great interest across various medical specialties, particularly among cardiologists who are now recognizing cardiac amyloidosis at an extraordinary pace. In all amyloidosis referral centers, we are observing a substantial increase in the prevalence of wild-type transthyretin (ATTRwt) cardiomyopathy, which is now becoming the most common form of cardiac amyloidosis.